Norton Rose Fulbright advises UG Healthcare Corporation Limited (Singapore) on acquisition of majority stake in Unigloves Germany

Global law firm Norton Rose Fulbright advised UG Healthcare Corporation Limited (Singapore) and its subsidiaries (Unigloves Singapore) on the acquisition of a majority stake in the German distribution company Unigloves GmbH (Unigloves Germany). Following the acquisition, Unigloves Singapore is now the sole shareholder of Unigloves GmbH.

Unigloves Germany is a distribution company for disposable medical products based in Troisdorf, Germany. The product portfolio includes the high-quality disposable examination gloves of the new majority shareholder Unigloves Singapore, as well as other disposable medical products under the UNIGLOVES brand, such as face masks, disinfectants and dental supplies. Unigloves Singapore is a listed brand manufacturer that distributes and sells its products through its own global downstream distribution network with a local presence in Europe, Asia, the USA and South America.

With the acquisition of the majority shareholding by Unigloves Singapore, the previous majority shareholder Grünwald Equity and managing director Robert Feldmeier as another minority shareholder, are divesting their shareholdings. Robert Feldmeier remains in his role as managing director of Unigloves GmbH.

Unigloves Singapore was advised by a Norton Rose Fulbright team led by Munich partner Bernd Dreier (Corporate / M&A). The team also consisted of Dr Bernhard Fiedler (Partner, Frankfurt, Banking / Finance), Dr Tim Schaper (Partner, Hamburg, Antitrust / FDI), Nils Kruse (Associate, Munich, Corporate / M&A), Kristina Thielemann (Associate, Frankfurt, Banking / Finance), Dr Tobias Teichner (Senior Associate) and Dr Noby Cyriac (Transaction Lawyer) (both Hamburg, Antitrust / FDI).

Grünwald Equity was advised by Philipp von Braunschweig and David Lübkemeier of POELLATH.